Pharmaceutical combination and uses thereof
- 专利权人:
- Bionomics Limited
- 发明人:
- Kremmidiotis, Gabriel,Lavranos, Tina,Inglis, Daniel
- 申请号：
- AU2016275574
- 公开号：
- AU2016275574A1
- 申请日:
- 2016.06.10
- 申请国别(地区):
- AU
- 年份:
- 2018
- 代理人:
- 摘要：
- The invention relates to pharmaceutical combinations comprising a vascular disrupting agent, in particular the tubulin polymerisation inhibitor BNC105, and an immunotherapeutic agent, in particular an anti-PD-L1, PD-1 or CTLA-4 antibody, and use thereof in the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NUCLEIC ACID MOLECULES AND RECOMBINANT VACCINES COMPRISING SEQUENCES ENCODING IMMUNOGENS AND IMMUNOMODULATORS, COMPOSITIONS COMPRISING SAID NUCLEIC ACID MOLECULES, AND USES OF SAID NUCLEIC ACID MOLECULES, RECOMBINANT VACCINES, COMPOSITIONS AND IMMUNOGENS AND IMMUNOMODULATORS IN THE PREPARATION OF MEDICAMENTS AND AS MEDICAMENTS
- SUBSTITUTED IMIDAZO RING SYSTEMS , PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE MANUFACTURE OF MEDICAMENTS
- Кристаллическая β-модификация 3-(4-амино-1-оксо-1,3-дигидро-2Н-изоиндол-2-ил)-пиперидин-2,6-диона, способ её получения и фармацевтическая композиция на её основе
- IIMMUNOMODULATOR
- ИММУНОМОДУЛИРУЮЩЕЕ СРЕДСТВО НА ОСНОВЕ 3-О-ПРОПИОНАТА АЛЛОБЕТУЛЕНОЛА (19β,28-ЭПОКСИ-18α-ОЛЕАНАН-3β-ИЛ И ПРОПИОНАТ)
